| 000 | 01711 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512003827.0 | ||
| 264 | 0 | _c19891114 | |
| 008 | 198911s 0 0 eng d | ||
| 022 | _a0026-0495 | ||
| 024 | 7 |
_a10.1016/0026-0495(89)90003-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChan, M K | |
| 245 | 0 | 0 |
_aGemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions. _h[electronic resource] |
| 260 |
_bMetabolism: clinical and experimental _cOct 1989 |
||
| 300 |
_a939-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aApolipoprotein A-I |
| 650 | 0 | 4 |
_aApolipoproteins A _xmetabolism |
| 650 | 0 | 4 |
_aApolipoproteins B _xmetabolism |
| 650 | 0 | 4 |
_aCholesterol _xmetabolism |
| 650 | 0 | 4 |
_aCholesterol, HDL _xmetabolism |
| 650 | 0 | 4 |
_aCholesterol, LDL _xmetabolism |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGemfibrozil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipidemias _xprevention & control |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 |
_aLipoprotein Lipase _xmetabolism |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xmetabolism |
| 650 | 0 | 4 |
_aLiver _xenzymology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeritoneal Dialysis, Continuous Ambulatory _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTriglycerides _xmetabolism |
| 773 | 0 |
_tMetabolism: clinical and experimental _gvol. 38 _gno. 10 _gp. 939-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0026-0495(89)90003-6 _zAvailable from publisher's website |
| 999 |
_c2513871 _d2513871 |
||